Are you Dr. Oudiz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
21840 Normandie Ave
Ste. 700
Torrance, CA 90502Phone+1 310-222-5101Fax+1 310-320-5463
Summary
- Dr. Ronald Oudiz, MD is a cardiologist in Torrance, California. He is currently licensed to practice medicine in California. He is affiliated with Harbor-UCLA Medical Center and Kaiser Permanente Los Angeles Medical Center.
Education & Training
- Los Angeles County-Harbor-UCLA Medical CenterFellowship, Cardiovascular Disease, 1992 - 1995
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1989 - 1990
- Keck School of Medicine of the University of Southern CaliforniaClass of 1989
Certifications & Licensure
- CA State Medical License 1990 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2002
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication Start of enrollment: 2010 Aug 01
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- 667 citationsRight Heart Adaptation to Pulmonary Arterial Hypertension: Physiology and PathobiologyAnton Vonk-Noordegraaf, Francois Haddad, Kelly Chin, Paul R. Forfia, Steven M. Kawut
Journal of the American College of Cardiology. 2013-12-24 - 54 citationsPatients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trialVallerie V. McLaughlin, Jean-Luc Vachiery, Ronald J. Oudiz, Stephan Rosenkranz, Nazzareno Galiè
The Journal of Heart and Lung Transplantation. 2019-12-01 - 234 citationsRiociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Rangi...Diana Bonderman, Stefano Ghio, Stephan B. Felix, Hossein Ardeschir Ghofrani, Evangelos D. Michelakis
Circulation. 2013-07-30
Press Mentions
- I’m Aware That I’m Rare: Alejandra HernandezApril 23rd, 2019
- ZappRx Implements Specialty Medication Prescribing Platform at 2 Pulmonary Medical CentersJuly 25th, 2017
- Reata Announces Initial Phase 2 Pulmonary Arterial Hypertension Data for Bardoxolone Methyl and Planned Initiation of Phase 3 StudyOctober 27th, 2015
- Join now to see all
Grant Support
- Exercise Rehabilitation In Pulmonary Arterial HypertensionNational Center For Research Resources2009–2010
- Cardiopulmonary Exercise Testing In Pulmonary HypertensionNational Center For Research Resources2006–2007
- Cardiopulmonary Exercise Testing: Pulmonary HypertensionNational Center For Research Resources2003–2007
Professional Memberships
- Fellow
- Member